An interrupted time series study of electronic health record clinical decision support for providers caring for patients with atrial fibrillation at increased stroke risk.

Autor: Osterland AJ; Baylor Scott & White Health, Temple, TX, USA., Yasuda M; Baylor Scott & White Health, Temple, TX, USA., Widmer RJ; Baylor Scott & White Health, Temple, TX, USA., Colavecchia AC; Pfizer Inc., New York, NY, USA., Gums T; Pfizer Inc., New York, NY, USA., Emir B; Pfizer Inc., New York, NY, USA., Nolen K; Pfizer Inc., New York, NY, USA., MacLean E; Pfizer Inc., New York, NY, USA., Godley PJ; Baylor Scott & White Health, Temple, TX, USA.

Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2023 Dec 05; Vol. 80 (24), pp. 1830-1839.

Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States.

Autor: Bhambri R; Pfizer Inc, New York, NY, USA. Rahul.Bhambri@pfizer.com., Colavecchia AC; Pfizer Inc, Houston, TX, USA., Bruno M; Pfizer Inc, New York, NY, USA., Chen Y; Pfizer Inc, Collegeville, PA, USA., Alvir J; Pfizer Inc, New York, NY, USA., Roy A; Pfizer Inc, New York, NY, USA., Kemner J; Pfizer Inc, Collegeville, PA, USA., Crowley A; Genesis Research, Hoboken, NJ, USA., Benjumea D; Genesis Research, Hoboken, NJ, USA., Gilstrap L; Cardiovascular Medicine Section, Dartmouth Health, Heart and Vascular Center, The Dartmouth Institute, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.

Publikováno v: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2023 Mar; Vol. 23 (2), pp. 197-206. Date of Electronic Publication: 2023 Feb 13.

Impact of Chlorhexidine Bathing on Antimicrobial Utilization in Surgical Intensive Care Unit.

Autor: Bui LN; Department of Pharmacy Practice, Samford University McWhorter School of Pharmacy, Birmingham, Alabama; Houston Methodist Research Institute, Houston, Texas., Swan JT; Houston Methodist Research Institute, Houston, Texas; Department of Pharmacy Services, Houston Methodist Hospital, Houston, Texas; Department of Surgery, Houston Methodist Hospital, Houston, Texas. Electronic address: swan.joshua@gmail.com., Perez KK; Houston Methodist Research Institute, Houston, Texas; Department of Pharmacy Services, Houston Methodist Hospital, Houston, Texas., Johnson ML; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, Texas., Chen H; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, Texas., Colavecchia AC; Department of Pharmacy Services, Houston Methodist Hospital, Houston, Texas., Rizk E; Houston Methodist Research Institute, Houston, Texas., Graviss EA; Houston Methodist Research Institute, Houston, Texas.

Publikováno v: The Journal of surgical research [J Surg Res] 2020 Jun; Vol. 250, pp. 161-171. Date of Electronic Publication: 2020 Feb 15.

Comparison of Levothyroxine Dosing in Patients with and without Heart Failure.

Autor: Yang T; Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA., Ruegger M; Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA., Colavecchia AC; Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA., Sadhu A; Department of Endocrinology, Houston Methodist Hospital, Houston, TX, USA., Patham B; Department of Endocrinology, Houston Methodist Hospital, Houston, TX, USA., Tatara A; Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.

Publikováno v: Endocrine research [Endocr Res] 2020 Feb; Vol. 45 (1), pp. 50-57. Date of Electronic Publication: 2019 Jul 26.

Quality indicators to measure the effect of opioid stewardship interventions in hospital and emergency department settings.

Autor: Rizk E; Department of Pharmacy, Houston Methodist, Houston, TX., Swan JT; Department of Pharmacy, Houston Methodist, Houston, TX.; Center for Outcomes Research, Houston Methodist Research Institute, Houston, TX., Cheon O; Center for Outcomes Research, Houston Methodist Research Institute, Houston, TX., Colavecchia AC; Department of Pharmacy, Houston Methodist, Houston, TX., Bui LN; Department of Pharmacy, Houston Methodist, Houston, TX., Kash BA; Center for Outcomes Research, Houston Methodist Research Institute, and School of Public Health, Texas A&M University, TX., Chokshi SP; Department of Neurosurgery, Houston Methodist Hospital, Houston, TX., Chen H; Department of Pharmaceutical Health Outcomes and Policy, University of Houston, Houston, TX., Johnson ML; Department of Pharmaceutical Health Outcomes and Policy, University of Houston, Houston, TX., Liebl MG; Department of Pharmacy, Houston Methodist, Houston, TX., Fink E; Department of Neurology, Houston Methodist Hospital, Houston, TX.

Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2019 Feb 01; Vol. 76 (4), pp. 225-235.